67 related articles for article (PubMed ID: 22886297)
1. Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.
Varbanov HP; Valiahdi SM; Kowol CR; Jakupec MA; Galanski MS; Keppler BK
Dalton Trans; 2012 Dec; 41(47):14404-14415. PubMed ID: 22886297
[TBL] [Abstract][Full Text] [Related]
2. A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.
Varbanov HP; Göschl S; Heffeter P; Theiner S; Roller A; Jensen F; Jakupec MA; Berger W; Galanski MS; Keppler BK
J Med Chem; 2014 Aug; 57(15):6751-64. PubMed ID: 25032896
[TBL] [Abstract][Full Text] [Related]
3. Platinum(IV) Complexes of
Papadia P; Micoli K; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230896
[TBL] [Abstract][Full Text] [Related]
4. Not the usual suspect - an unexpected organometallic product during the synthesis of cytotoxic platinum(II) complexes.
Maier T; Wutschitz J; Gajic N; Hejl M; Cseh K; Mai S; Jakupec MA; Galanski MS; Keppler BK
Dalton Trans; 2023 Nov; 52(44):16326-16335. PubMed ID: 37855721
[TBL] [Abstract][Full Text] [Related]
5. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.
Navas F; Chocarro-Calvo A; Iglesias-Hernández P; Fernández-García P; Morales V; García-Martínez JM; Sanz R; De la Vieja A; García-Jiménez C; García-Muñoz RA
J Med Chem; 2024 Apr; 67(8):6410-6424. PubMed ID: 38592014
[TBL] [Abstract][Full Text] [Related]
6. Thermoresponsive carboplatin-releasing prodrugs.
McAdam AD; Batchelor LK; Romano-deGea J; Vasilyev D; Dyson PJ
J Inorg Biochem; 2024 May; 254():112505. PubMed ID: 38377623
[TBL] [Abstract][Full Text] [Related]
7. Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer.
Sabbatini M; Zanellato I; Ravera M; Gabano E; Perin E; Rangone B; Osella D
J Med Chem; 2019 Apr; 62(7):3395-3406. PubMed ID: 30879295
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen
Ravera M; Zanellato I; Gabano E; Perin E; Rangone B; Coppola M; Osella D
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238499
[TBL] [Abstract][Full Text] [Related]
9. Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity.
Aputen AD; Elias MG; Gilbert J; Sakoff JA; Gordon CP; Scott KF; Aldrich-Wright JR
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396859
[TBL] [Abstract][Full Text] [Related]
10. The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs - an HPLC-ICP-MS study.
Theiner S; Grabarics M; Galvez L; Varbanov HP; Sommerfeld NS; Galanski MS; Keppler BK; Koellensperger G
Dalton Trans; 2018 Apr; 47(15):5252-5258. PubMed ID: 29560976
[TBL] [Abstract][Full Text] [Related]
11. Insights into the acid-base properties of Pt(IV)-diazidodiam(m)inedihyroxido complexes from multinuclear NMR spectroscopy.
Ronconi L; Pizarro AM; McQuitty RJ; Sadler PJ
Chemistry; 2011 Oct; 17(43):12051-8. PubMed ID: 21922567
[TBL] [Abstract][Full Text] [Related]
12. Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs.
Markova L; Maji M; Kostrhunova H; Novohradsky V; Kasparkova J; Gibson D; Brabec V
J Med Chem; 2024 Jun; 67(11):9745-9758. PubMed ID: 38819023
[TBL] [Abstract][Full Text] [Related]
13. Insertion of (Bioactive) Equatorial Ligands into Platinum(IV) Complexes.
Kastner A; Schueffl H; Yassemipour PA; Keppler BK; Heffeter P; Kowol CR
Angew Chem Int Ed Engl; 2023 Nov; 62(46):e202311468. PubMed ID: 37703130
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations.
Song Y; Suntharalingam K; Yeung JS; Royzen M; Lippard SJ
Bioconjug Chem; 2013 Oct; 24(10):1733-40. PubMed ID: 23957697
[TBL] [Abstract][Full Text] [Related]
15. Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological Activity.
Liu X; Barth MC; Cseh K; Kowol CR; Jakupec MA; Keppler BK; Gibson D; Weigand W
Chem Biodivers; 2022 Oct; 19(10):e202200695. PubMed ID: 36026613
[TBL] [Abstract][Full Text] [Related]
16. Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity.
Aher S; Zhu J; Bhagat P; Borse L; Liu X
Top Curr Chem (Cham); 2024 Feb; 382(1):6. PubMed ID: 38400859
[TBL] [Abstract][Full Text] [Related]
17. Visible light-activatable platinum(IV) prodrugs harnessing CD36 for ovarian cancer therapy.
Jayawardhana AMDS; Bhandari S; Kaspi-Kaneti AW; Kshetri M; Qiu Z; Cheline M; Shen H; Dunietz BD; Zheng YR
Dalton Trans; 2023 Aug; 52(31):10942-10950. PubMed ID: 37490033
[TBL] [Abstract][Full Text] [Related]
18. Spectroscopic Studies on Photoinduced Reactions of the Anticancer Prodrug, trans,trans,trans-[Pt(N
Vernooij RR; Joshi T; Horbury MD; Graham B; Izgorodina EI; Stavros VG; Sadler PJ; Spiccia L; Wood BR
Chemistry; 2018 Apr; 24(22):5790-5803. PubMed ID: 29314368
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) Diazido Anticancer Prodrug Candidate.
Vernooij RR; Joshi T; Shaili E; Kubeil M; Appadoo DR; Izgorodina EI; Graham B; Sadler PJ; Wood BR; Spiccia L
Inorg Chem; 2016 Jun; 55(12):5983-92. PubMed ID: 27257848
[TBL] [Abstract][Full Text] [Related]
20. Highly photoactive Ir(III)-Pt(IV) heterometallic conjugates for anticancer therapy.
Hu W; Liu R; Zheng K; Wang Z
Chem Commun (Camb); 2024 Jan; 60(4):388-391. PubMed ID: 38054250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
